BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

703 related articles for article (PubMed ID: 19884662)

  • 21. 'Silent' somatotropinoma.
    Pawlikowski M; Kuta J; Fuss-Chmielewska J; Winczyk K
    Endokrynol Pol; 2012; 63(2):88-91. PubMed ID: 22538745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and Treatment of Acromegaly: An Update.
    Ershadinia N; Tritos NA
    Mayo Clin Proc; 2022 Feb; 97(2):333-346. PubMed ID: 35120696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Modern Criteria for Medical Management of Acromegaly.
    Frara S; Maffezzoni F; Mazziotti G; Giustina A
    Prog Mol Biol Transl Sci; 2016; 138():63-83. PubMed ID: 26940387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A registry of acromegaly patients and one year following up in Taiwan.
    Tseng FY; Huang TS; Lin JD; Chen ST; Wang PW; Chen JF; Huey-Herng Sheu W; Chang TC;
    J Formos Med Assoc; 2019 Oct; 118(10):1430-1437. PubMed ID: 30612883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [CLINICAL, BIOCHEMICAL AND HORMONAL PREDICTORS OF LEFT VENTRICULAR HYPERTROPHY IN PATIENTS WITH ACROMEGALY].
    Mykytyuk MR
    Lik Sprava; 2015; (5-6):34-40. PubMed ID: 27089713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beneficial effect of dose escalation and surgical debulking in patients with acromegaly treated with somatostatin analogs in a Romanian tertiary care center.
    Gheorghiu ML; Găloiu S; Vintilă M; Purice M; Hortopan D; Dumitraşcu A; Coculescu M; Poiană C
    Hormones (Athens); 2016 Apr; 15(2):224-234. PubMed ID: 27376425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly.
    Colao A; Auriemma RS; Pivonello R
    Pituitary; 2016 Apr; 19(2):210-21. PubMed ID: 26290466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone-secreting adenomas: pathology and cell biology.
    Lopes MB
    Neurosurg Focus; 2010 Oct; 29(4):E2. PubMed ID: 20887127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current management of acromegaly.
    Díez JJ; Iglesias P
    Expert Opin Pharmacother; 2000 Jul; 1(5):991-1006. PubMed ID: 11249504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Factors of Acromegalic Patients with Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Surgery.
    Taweesomboonyat C; Oearsakul T
    World Neurosurg; 2021 Feb; 146():e1360-e1366. PubMed ID: 33309643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acromegaly].
    Chanson P
    Presse Med; 2009 Jan; 38(1):92-102. PubMed ID: 19004612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly.
    Colao A; Attanasio R; Pivonello R; Cappabianca P; Cavallo LM; Lasio G; Lodrini A; Lombardi G; Cozzi R
    J Clin Endocrinol Metab; 2006 Jan; 91(1):85-92. PubMed ID: 16263832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acromegaly and pregnancy.
    Caron P
    Ann Endocrinol (Paris); 2011 Sep; 72(4):282-286. PubMed ID: 21820101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Advances in the treatment of acromegaly].
    Krysiak R; Okopień B; Marek B
    Pol Merkur Lekarski; 2008 Jan; 24(139):59-65. PubMed ID: 18634256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of persistent and recurrent acromegaly.
    Del Porto LA; Liubinas SV; Kaye AH
    J Clin Neurosci; 2011 Feb; 18(2):181-90. PubMed ID: 21167718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis and treatment of acromegaly.
    Katznelson L
    Growth Horm IGF Res; 2005 Jul; 15 Suppl A():S31-5. PubMed ID: 16023876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years.
    Abbassioun K; Amirjamshidi M; Mehrazin A; Khalatbary I; Keynama M; Bokai H; Abdollahi M
    Surg Neurol; 2006 Jul; 66(1):26-31; discussion 31. PubMed ID: 16793431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Control of growth hormone and IGF1 in patients with acromegaly in the UK: responses to medical treatment with somatostatin analogues and dopamine agonists.
    Howlett TA; Willis D; Walker G; Wass JA; Trainer PJ;
    Clin Endocrinol (Oxf); 2013 Nov; 79(5):689-99. PubMed ID: 23574573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discordance between growth hormone and insulin-like growth factor-1 after pituitary surgery for acromegaly: a stepwise approach and management.
    Zeinalizadeh M; Habibi Z; Fernandez-Miranda JC; Gardner PA; Hodak SP; Challinor SM
    Pituitary; 2015 Feb; 18(1):48-59. PubMed ID: 24496953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormonal diagnosis of GH hypersecretory states.
    Grottoli S; Gasco V; Ragazzoni F; Ghigo E
    J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.